NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT2080225104

Registered date:03/03/2020

Basic Information

Recruitment status completed
Health condition(s) or Problem(s) studied
Date of first enrollment06/04/2020
Target sample size150
Countries of recruitmentJapan,Asia except Japan,North America,South America,Europe
Study typeInterventional
Intervention(s)investigational material(s) Generic name etc : INN of investigational material : dupilumab Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcomeefficacy
Secondary Outcomeefficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy efficacy safety other

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximum<= 80age old
GenderBoth
Include criteria
Exclude criteria

Related Information

Contact

Public contact
Name
Address
Telephone +81-3-6301-3670
E-mail clinical-trials-jp@sanofi.com
Affiliation
Scientific contact
Name
Address
Telephone +81-3-6301-3670
E-mail clinical-trials-jp@sanofi.com
Affiliation